3859 results for «2293»

Filter By

3859 results

What an interventional cardiologist should know about anti-thrombotics

22 May 2025 – From EuroPCR 2025

This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.

What an interventional cardiologist should know about anti-thrombotics

Procedural planning and risk stratification in multivessel PCI

22 May 2025 – From EuroPCR 2025

This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.

Procedural planning and risk stratification in multivessel PCI

What did we learn from my TAVI complications?

22 May 2025 – From EuroPCR 2025

Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.

What did we learn from my TAVI complications?

Advanced tools for the diagnosis of coronary artery disease

22 May 2025 – From EuroPCR 2025

This session highlights advanced diagnostic tools for coronary artery disease, focusing on innovative pressure gradient assessments, computed tomography perfusion accuracy in stented patients, head-to-head comparisons of IQ-FFR with invasive FFR, and comprehensive evaluations of coronary physiology and plaque vulnerability derived from angiography.

Advanced tools for the diagnosis of coronary artery disease

Clinical and technical factors for decision-making in treatment of left main coronary artery disease

22 May 2025 – From EuroPCR 2025

Delve into decision-making factors in treating left main coronary artery disease, particularly in challenging scenarios. This session discusses the application of new SOLACI guidelines, critical strategy reflections, and real-world cases illustrating optimal left main PCI approaches.

Clinical and technical factors for decision-making in treatment of left main coronary artery disease

Challenges and risks of percutaneous treatment of calcified lesions

22 May 2025 – From EuroPCR 2025

Learn how to effectively manage calcified coronary lesions and their associated risks in this focused session. Understand the critical role of plaque modification and intravascular imaging, and gain insights into addressing stent thrombosis following interventions on calcified lesions through detailed case analyses.

Challenges and risks of percutaneous treatment of calcified lesions

Patients with degenerated aortic bioprothesis - Every case is different

22 May 2025 – From EuroPCR 2025

Delve into the nuanced management of patients with degenerated aortic bioprostheses, emphasizing that no two cases are alike. This session provides expert insights into selecting optimal valve-in-valve TAVI approaches tailored to individual anatomy and clinical context. Learn practical strategies to overcome complex challenges such as coronary...

Patients with degenerated aortic bioprothesis - Every case is different

Optimised patient selection for carotid artery stenting

22 May 2025 – From EuroPCR 2025

Optimize patient selection for carotid artery stenting with this session that highlights personalized approaches to ischaemic stroke treatment. Review bioactive stents versus endovascular therapy, feasibility and outcomes in near-occlusion cases, and long-term retrospective analyses supporting carotid stenting as a strategic ally in embolic stroke management.

Optimised patient selection for carotid artery stenting

Contemporary outcomes of PCI patients

22 May 2025 – From EuroPCR 2025

Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.

Contemporary outcomes of PCI patients

New frontier in renal denervation: data, devices and developments

22 May 2025 – From EuroPCR 2025

Advance your understanding of renal denervation with the latest data, innovative devices, and emerging developments. This session reviews the 12-month results of the REDUCED 1 trial evaluating the TIVUS system, explores safety and efficacy of novel renal stimulation techniques, and presents outcomes from registries including patients...

New frontier in renal denervation: data, devices and developments

Updates on percutaneous treatment of pulmonary embolism

22 May 2025 – From EuroPCR 2025

Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.

Updates on percutaneous treatment of pulmonary embolism

Advancing knowledge and innovations in peripheral interventions

22 May 2025 – From EuroPCR 2025

Expand your expertise in peripheral interventions with a focus on recent innovations and clinical insights. This session covers pre-clinical results of a novel Hybrid Drug-Eluting Stent for below-the-knee arteries, the prognostic impact of proteinuria in LEAD patients with chronic kidney disease, beta-blocker therapy effects post-frozen elephant...

Advancing knowledge and innovations in peripheral interventions

Leaflet modification to prevent coronary obstruction during TAVI

22 May 2025 – From EuroPCR 2025

This session addresses advanced leaflet modification techniques to prevent coronary obstruction during TAVI. Learn from detailed cases involving valve-in-valve interventions, treatment of failed stentless valves, homograft management, and dedicated devices for leaflet modification prior to valve-in-valve and valve-in-valve-in-valve procedures.

Leaflet modification to prevent coronary obstruction during TAVI

The role of DCB in non-left main true bifurcations

22 May 2025 – From EuroPCR 2025

This session offers a detailed exploration of drug-coated balloon (DCB) use in non-left main true bifurcation lesions. Learn to define suitable lesion characteristics for provisional stenting, understand stepwise procedural strategies minimizing implanted material, and appreciate the role of intravascular imaging in assessing bifurcation complexity and optimizing...

The role of DCB in non-left main true bifurcations

Shock and PCI: due to ECMO I survived

22 May 2025 – From EuroPCR 2025

Explore life-saving strategies in the management of cardiogenic shock complicating PCI, with emphasis on ECMO utilization. This session reviews challenging cardiac arrest cases, multi-culprit STEMI scenarios, and innovative STEMI treatments in critical patients, illustrating how ECMO support can be pivotal in survival and recovery.

Shock and PCI: due to ECMO I survived

Management of complex left main trifurcation lesion

22 May 2025 – From EuroPCR 2025

This session focuses on the management of complex left main trifurcation lesions. Review hybrid and double TAP techniques, long-term follow-up outcomes, and innovative approaches such as the inverted double TAP technique, offering insights into optimizing treatment strategies for these challenging anatomical scenarios.

Management of complex left main trifurcation lesion

Pharmacotherapy coronary interventions: new insights

22 May 2025 – From EuroPCR 2025

Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...

Pharmacotherapy coronary interventions: new insights

Challenging tricuspid TEER cases

22 May 2025 – From EuroPCR 2025

Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.

Challenging tricuspid TEER cases

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

22 May 2025 – From EuroPCR 2025

Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

Troubleshooting and management communication in LAA closure

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on troubleshooting and communication during left atrial appendage (LAA) closure procedures. Covering device migration management, transeptal puncture in high bleeding risk patients, scoliosis adaptations, and advanced catheter techniques, it emphasizes practical solutions for procedural complications.

Troubleshooting and management communication in LAA closure
Didn’t find what you were looking for?